- Assistant Clinical Investigator, Critical Care Medicine Department
Dr. Torabi-Parizi earned her undergraduate degree and degree in Medicine from Emory University. She completed her internship and residency training in Internal Medicine at the Johns Hopkins Hospital Osler Training Program. Dr. Torabi-Parizi completed her fellowship training in Critical Care Medicine at the NIH and was subsequently appointed as Staff Clinician in the Critical Care Medicine Department at the NIH in 2011. She became an Assistant Clinical Investigator in the Critical Care Medicine Department in 2013. She also chairs the Clinical Center CPR committee.
- (2020). Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic Review. CRITICAL CARE MEDICINE. 48(9), 1365-1374.
- (2020). Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis. Intensive Care Medicine Experimental. 8(1),
- (2019). The Chemoattractant Receptor Ebi2 Drives Intranodal Naive CD4(+) T Cell Peripheralization to Promote Effective Adaptive Immunity. IMMUNITY. 50(5), 1188-+.
- (2018). Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 197(6), 708-727.